BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34031899)

  • 21. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
    Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
    Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
    Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
    BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
    Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
    Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
    Sharif EU; Kalisiak J; Lawson KV; Miles DH; Newcomb E; Lindsey EA; Rosen BR; Debien LPP; Chen A; Zhao X; Young SW; Walker NP; Sträter N; Scaletti ER; Jin L; Xu G; Leleti MR; Powers JP
    J Med Chem; 2021 Jan; 64(1):845-860. PubMed ID: 33399453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix.
    Zhou P; Zhi X; Zhou T; Chen S; Li X; Wang L; Yin L; Shao Z; Ou Z
    Cancer Biol Ther; 2007 Mar; 6(3):426-31. PubMed ID: 17471030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
    Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
    Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
    Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perivascular CD73
    Perry HM; Görldt N; Sung SJ; Huang L; Rudnicka KP; Encarnacion IM; Bajwa A; Tanaka S; Poudel N; Yao J; Rosin DL; Schrader J; Okusa MD
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F658-F669. PubMed ID: 31364375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
    Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
    Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
    Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
    Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD73 slows down migration of skin dendritic cells, affecting the sensitization phase of contact hypersensitivity reactions in mice.
    Neuberger A; Ring S; Silva-Vilches C; Schrader J; Enk A; Mahnke K
    J Dermatol Sci; 2017 Sep; 87(3):292-299. PubMed ID: 28743609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases.
    Bertoni APS; de Campos RP; Tamajusuku ASK; Stefani GP; Braganhol E; Battastini AMO; Wink MR
    Life Sci; 2020 Sep; 256():117862. PubMed ID: 32473244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.
    Katsuta E; Tanaka S; Mogushi K; Shimada S; Akiyama Y; Aihara A; Matsumura S; Mitsunori Y; Ban D; Ochiai T; Kudo A; Fukamachi H; Tanaka H; Nakayama K; Arii S; Tanabe M
    Int J Oncol; 2016 Feb; 48(2):657-69. PubMed ID: 26691441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host surface ectonucleotidase-CD73 and the opportunistic pathogen,
    Lee JS; Chowdhury N; Roberts JS; Yilmaz Ö
    Virulence; 2020 Dec; 11(1):414-429. PubMed ID: 32419582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
    Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
    Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State.
    Nguyen AM; Zhou J; Sicairos B; Sonney S; Du Y
    Mol Cell Proteomics; 2020 Feb; 19(2):375-389. PubMed ID: 31879272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and Function of Non-cell-bound CD73 in Inflammation.
    Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
    Front Immunol; 2019; 10():1729. PubMed ID: 31404305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy induces enrichment of CD47
    Samanta D; Park Y; Ni X; Li H; Zahnow CA; Gabrielson E; Pan F; Semenza GL
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1239-E1248. PubMed ID: 29367423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular NAD
    Wilk A; Hayat F; Cunningham R; Li J; Garavaglia S; Zamani L; Ferraris DM; Sykora P; Andrews J; Clark J; Davis A; Chaloin L; Rizzi M; Migaud M; Sobol RW
    Sci Rep; 2020 Jan; 10(1):651. PubMed ID: 31959836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.